scholarly journals Two, three, or not to be? Elucidating Multiple Bonding in d6 Pseudotetrahedral Oxo and Imide Complexes

Author(s):  
Joel Gardner ◽  
Joseph Schneider ◽  
John Anderson

Late transition metal oxo and imide complexes play an important role in the catalytic functionalization and activation of small molecules. An emerging theme in this area over the past few decades has been the use of lower-coordination numbers, and pseudo-tetrahedral geometries in particular, to stabilize what would otherwise be highly reactive species. However, the bonding structure in d<sup>6</sup> oxo and imide complexes in this geometry is ambiguous. These species are typically depicted with a triple bond, however recent experimental evidence suggests significant empirical differences between these complexes and other triply bonded complexes with lower d-counts. Here we use a suite of computational orbital localization methods and electron density analyses to probe the bonding structure of isoelectronic d<sup>6</sup> Co(III) oxo and imide complexes. These analyses suggest that a triple bond description is inaccurate due to a dramatically weakened σ interaction. While the exact bond order in these cases is necessarily dependent on the model used, several metrics suggest that the strength of the metal–O/N bond is most similar to other formally doubly bonded complexes.

2021 ◽  
Author(s):  
Joel Gardner ◽  
Joseph Schneider ◽  
John Anderson

Late transition metal oxo and imide complexes play an important role in the catalytic functionalization and activation of small molecules. An emerging theme in this area over the past few decades has been the use of lower-coordination numbers, and pseudo-tetrahedral geometries in particular, to stabilize what would otherwise be highly reactive species. However, the bonding structure in d<sup>6</sup> oxo and imide complexes in this geometry is ambiguous. These species are typically depicted with a triple bond, however recent experimental evidence suggests significant empirical differences between these complexes and other triply bonded complexes with lower d-counts. Here we use a suite of computational orbital localization methods and electron density analyses to probe the bonding structure of isoelectronic d<sup>6</sup> Co(III) oxo and imide complexes. These analyses suggest that a triple bond description is inaccurate due to a dramatically weakened σ interaction. While the exact bond order in these cases is necessarily dependent on the model used, several metrics suggest that the strength of the metal–O/N bond is most similar to other formally doubly bonded complexes.


2019 ◽  
Vol 26 (8) ◽  
pp. 1351-1365 ◽  
Author(s):  
Zhentao Huang ◽  
Qingxin Yao ◽  
Simin Wei ◽  
Jiali Chen ◽  
Yuan Gao

Precision medicine is in an urgent need for public healthcare. Among the past several decades, the flourishing development in nanotechnology significantly advances the realization of precision nanomedicine. Comparing to well-documented nanoparticlebased strategy, in this review, we focus on the strategy using enzyme instructed selfassembly (EISA) in biological milieu for theranostics purpose. In principle, the design of small molecules for EISA requires two aspects: (1) the substrate of enzyme of interest; and (2) self-assembly potency after enzymatic conversion. This strategy has shown its irreplaceable advantages in nanomedicne, specifically for cancer treatments and Vaccine Adjuvants. Interestingly, all the reported examples rely on only one kind of enzymehydrolase. Therefore, we envision that the application of EISA strategy just begins and will lead to a new paradigm in nanomedicine.


2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Chen Wang ◽  
Jiawei Zhang ◽  
Jie Yin ◽  
Yichao Gan ◽  
Senlin Xu ◽  
...  

AbstractThe Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL, which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc, respectively. Myc protein orchestrates diverse physiological processes, including cell proliferation, differentiation, survival, and apoptosis. Myc modulates about 15% of the global transcriptome, and its deregulation rewires the cellular signaling modules inside tumor cells, thereby acquiring selective advantages. The deregulation of Myc occurs in >70% of human cancers, and is related to poor prognosis; hence, hyperactivated Myc oncoprotein has been proposed as an ideal drug target for decades. Nevertheless, no specific drug is currently available to directly target Myc, mainly because of its “undruggable” properties: lack of enzymatic pocket for conventional small molecules to bind; inaccessibility for antibody due to the predominant nucleus localization of Myc. Although the topic of targeting Myc has actively been reviewed in the past decades, exciting new progresses in this field keep emerging. In this review, after a comprehensive summarization of valuable sources for potential druggable targets of Myc-driven cancer, we also peer into the promising future of utilizing macropinocytosis to deliver peptides like Omomyc or antibody agents to intracellular compartment for cancer treatment.


2021 ◽  
Vol 22 (4) ◽  
pp. 2008
Author(s):  
Jinsha Liu ◽  
Priyanka Pandya ◽  
Sepideh Afshar

Around 77 new oncology drugs were approved by the FDA in the past five years; however, most cancers remain untreated. Small molecules and antibodies are dominant therapeutic modalities in oncology. Antibody-drug conjugates, bispecific antibodies, peptides, cell, and gene-therapies are emerging to address the unmet patient need. Advancement in the discovery and development platforms, identification of novel targets, and emergence of new technologies have greatly expanded the treatment options for patients. Here, we provide an overview of various therapeutic modalities and the current treatment options in oncology, and an in-depth discussion of the therapeutics in the preclinical stage for the treatment of breast cancer, lung cancer, and multiple myeloma.


Author(s):  
Venkatesh Piradi ◽  
Feng Yan ◽  
Xunjin Zhu ◽  
Wai-Yeung Raymond Wong

Organic solar cells (OSCs) have been considered as a promising cost-effective alternative to silicon-based solar cell counterparts due to their lightweight, mechanical flexibility, and easy fabrication features. Over the past...


Molecules ◽  
2020 ◽  
Vol 25 (3) ◽  
pp. 593
Author(s):  
Juan Miranda-Pizarro ◽  
Macarena G. Alférez ◽  
M. Dolores Fernández-Martínez ◽  
Eleuterio Álvarez ◽  
Celia Maya ◽  
...  

A straightforward method for the preparation of trisphosphinite ligands in one step, using only commercially available reagents (1,1,1-tris(4-hydroxyphenyl)ethane and chlorophosphines) is described. We have made use of this approach to prepare a small family of four trisphosphinite ligands of formula [CH3C{(C6H4OR2)3], where R stands for Ph (1a), Xyl (1b, Xyl = 2,6-Me2-C6H3), iPr (1c), and Cy (1d). These polyfunctional phosphinites allowed us to investigate their coordination chemistry towards a range of late transition metal precursors. As such, we report here the isolation and full characterization of a number of Au(I), Ag(I), Cu(I), Ir(III), Rh(III) and Ru(II) homotrimetallic complexes, including the structural characterization by X-ray diffraction studies of six of these compounds. We have observed that the flexibility of these trisphosphinites enables a variety of conformations for the different trimetallic species.


Sign in / Sign up

Export Citation Format

Share Document